Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Adherium.
RELATED STOCKHEAD STORIES
News
Closing Bell: Late buyers save the ASX from its biggest daily fall of the year
News
ASX Small Cap Lunch Wrap: Who’s just riding the wave today?
Health & Biotech
ASX Health Stocks: Adherium races ahead 30pc on FDA clearance, Epsilon jumps 20pc on new cannabis partnership
News
10 at 10: These ASX stocks are the most in vogue with investor tastes this morning
Health & Biotech
These 3 ASX health stocks just took their next steps towards entering the USA
News
10 at 10: Investors are feeling festive for these ASX stocks this morning
Experts
ScoPo’s Powerplays: Health sector trades sideways but M&A plays coloured the week
News
Quarterlies recap: Here are five Q1 updates you may have missed this afternoon
Health & Biotech
Digital therapeutics set to be the next healthcare wave; but Australia is at risk of missing out
News
Rise and Shine: What you need to know before the ASX opens
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
ASX asthma stocks: Global Health becomes the latest contender
Health & Biotech
Here are the top adopters of telehealth — and the biggest ASX winners
News
The industries likely to stick with their COVID-19 operational shifts
Health & Biotech
Check up: COVID-19 still sells but investors are looking for the next endorphin hit
Health & Biotech
Medtech needs more than a TGA tick to hit the big $$$
Health & Biotech
